Bhaumik Pandya

Bhaumik A. Pandya has a strong background in chemistry, with extensive experience working in various pharmaceutical and research companies. Currently holding a senior director position at Vigil Neuroscience, Bhaumik previously served as a principal scientist at Alnylam Pharmaceuticals and held senior roles at Amgen, Yumanity Therapeutics, Cubist Pharmaceuticals, Concert Pharmaceuticals, and The Broad Institute of MIT & Harvard. Bhaumik earned a Doctorate in Chemistry from Boston College and a Bachelor of Science in Chemistry from The College of New Jersey.